By Aditya Raghunath
Investing.com -- IRCTC stock has roared back to life in the last three days. From May 2020 until December 3, IRCTC (NS: INIR ) stock was drifting around in the range of Rs 1,300 - Rs 1,400. After all, no one was traveling by train. However, since then, the stock has gained almost 24% since it closed at Rs 1,354 on December 2.
The rally is on the back of positive news on vaccine development and deployment. IRCTC bulls have reacted positively to the formal application of the Serum Institute of India to Drugs Controller General of India (DCGI) for emergency authorization for the Oxford COVID-19 vaccine in the country. US drugmaker Pfizer (NYSE: PFE ) has also sought approval to deploy its vaccine in India. The UK will rollout Pfizer’s vaccine in the country from Thursday, December 10.
The Indian government has said that it is in talks with state governments across the country to ensure that vaccine prices will be kept in check and that it will be available throughout the country.
COVID-19 cases seem to be slowing down in certain hotspots in the country. Active cases in Maharashtra, the state that has recorded the most number of cases and deaths, have dropped to 75,767, the lowest in 5 months according to news reports.
All of these pieces of news have improved prospects of travel in the country. If India is able to continue on this path, the IRCTC rally can definitely continue. It is still off its February peak of Rs 1,994 by almost 19%.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.